- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Lenvatinib – March 2016
Lenvatinib: 4 mg capsule, 3010 mg capsule, 30, Lenvima®
Last updated
1 July 2016